{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T21:57:44Z","timestamp":1781215064330,"version":"3.54.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[1998,6,1]],"date-time":"1998-06-01T00:00:00Z","timestamp":896659200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Klin"],"published-print":{"date-parts":[[1998,6]]},"DOI":"10.1007\/bf03044679","type":"journal-article","created":{"date-parts":[[2009,6,6]],"date-time":"2009-06-06T00:12:59Z","timestamp":1244247179000},"page":"352-359","source":"Crossref","is-referenced-by-count":35,"title":["Wirkung von Pamidronat auf Beschwerdebild und Knochenstoffwechsel bei fibr\u00f6ser Dysplasie und McCune-Albright-Syndrom","Effects of pamidronate on clinical symptoms and bone metabolism in patients with fibrous dysplasia and McCune-Albright syndrome"],"prefix":"10.1007","volume":"93","author":[{"given":"Johannes","family":"Pfeilschifter","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BF03044679_CR1","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJM193704292161701","volume":"216","author":"F Albright","year":"1936","unstructured":"Albright F, Butler AM, Hampton AO, et al. Syndrome characterized by osteoitis fibrosa disseminata, areas of pigmentation and endocrine dysfunction, with precocious puberty in females: report of five cases. N Engl J Med 1936;216:727\u201346.","journal-title":"N Engl J Med"},{"key":"BF03044679_CR2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1210\/jcem-31-3-283","volume":"31","author":"NH Bell","year":"1970","unstructured":"Bell NH, Avery S, Johnston CC. Effects of calcitonin in Paget\u2019s disease and polyostotic fibrous dysplasia. J Clin Endocrinol 1970;31:283\u201390.","journal-title":"J Clin Endocrinol"},{"issue":"Suppl 1","key":"BF03044679_CR3","first-page":"249","volume":"11","author":"H Bone","year":"1996","unstructured":"Bone H, Cody D, Siris E, et al. Intravenous pamidronate treatment of fibrous dysplasia of bone. J Bone Miner Res 1996;11:Suppl 1: S 249.","journal-title":"J Bone Miner Res"},{"key":"BF03044679_CR4","first-page":"80","volume":"28","author":"R Chetty","year":"1990","unstructured":"Chetty R, Kalan MR, Kranold DH. Malignant transformation in fibrous dysplasia. S Afr J Surg 1990;28:80\u20132.","journal-title":"S Afr J Surg"},{"key":"BF03044679_CR5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/ajmg.1320140414","volume":"14","author":"DE Cole","year":"1983","unstructured":"Cole DE, Fraser FC, Glorieux FH, et al. Panostostic fibrous dysplasia: a congenital disorder of bone with unusual facial appearance, bone fragility, hyperphosphataemia and hypophosphataemia. Am J Med Genet 1983;14:725\u201335.","journal-title":"Am J Med Genet"},{"key":"BF03044679_CR6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1136\/bmj.309.6956.711","volume":"309","author":"JE Compston","year":"1994","unstructured":"Compston JE. The therapeutic use of bisphosphonates. Br Med J 1994;309:711\u20135.","journal-title":"Br Med J"},{"key":"BF03044679_CR7","first-page":"64","volume":"1","author":"A Enderle","year":"1992","unstructured":"Enderle A. Fibrose Dysplasie \u2014 eine klassische Knochenerkrankung aktualisiert. Osteologie 1992;1:64\u20138.","journal-title":"Osteologie"},{"key":"BF03044679_CR8","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2165\/00003495-199141020-00009","volume":"41","author":"A Fitton","year":"1991","unstructured":"Fitton A, McTavish D. Pamidronate \u2014 A review of its pharmacological properties and therapeutic efficacy in resorptive bone disease. Drugs 1991;41:289\u2013318.","journal-title":"Drugs"},{"key":"BF03044679_CR9","first-page":"523","volume":"8","author":"H Fleisch","year":"1987","unstructured":"Fleisch H. Bisphosphonates \u2014 history and experimental basis. Bone 1987;8:Suppl:523\u20138.","journal-title":"Bone"},{"key":"BF03044679_CR10","first-page":"71","volume":"77","author":"JW Frise","year":"1957","unstructured":"Frise JW. The roentgen features of fibrous dysplasia of the skull and facial bones: a critical analysis of thirty-nine pathologically proven cases. AJR 1957;77:71\u201388.","journal-title":"AJR"},{"key":"BF03044679_CR11","first-page":"753-7","volume-title":"Metabolic bone disease and clinically related disorders","author":"MC Gebhardt","year":"1990","unstructured":"Gebhardt MC, Mankin HJ. The diagnosis and management of bone tumors. In: Aviolo LV, Krane SM, eds. Metabolic bone disease and clinically related disorders, Philadelphia: WB Saunders, 1990:753-7\u201392."},{"key":"BF03044679_CR12","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/8756-3282(96)87996-8","volume":"17","author":"FH Glorieux","year":"1995","unstructured":"Glorieux FH, Travers R, Lanoue G. Pamidronate treatment in children with fibrous dysplasia and osteogenesis imperfecta. Bone 1995;17:611 abstract","journal-title":"Bone"},{"key":"BF03044679_CR13","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/0030-4220(84)90282-2","volume":"57","author":"MB Hall","year":"1984","unstructured":"Hall MB, Sclar AG, Gardner DF. Albright\u2019s syndrome with reactivation of fibrous dysplasia secondary to pituitary adenoma. Oral Surg 1984;57:616\u20139.","journal-title":"Oral Surg"},{"key":"BF03044679_CR14","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/17453677908989764","volume":"50","author":"A Hjelmstedt","year":"1979","unstructured":"Hjelmstedt A, Ljunghall S. A case of Albright\u2019s syndrome treated with calcitonin. Acta Orthop Scand 1979;50:251\u20133.","journal-title":"Acta Orthop Scand"},{"key":"BF03044679_CR15","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJM198808183190707","volume":"319","author":"FS Kaplan","year":"1988","unstructured":"Kaplan FS, Fallon MD, Boden SD, et al. Estrogen receptors in bone in a patient with polyostotic fibrous dysplasia (McCune-Albright syndrome). N Engl J Med 1988 319:241\u20135.","journal-title":"N Engl J Med"},{"key":"BF03044679_CR16","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1056\/NEJM199112123252410","volume":"325","author":"MA Levine","year":"1991","unstructured":"Levine MA. The McCune-Albright syndrome: the whys and wherefores of abnormal signal transduction. N Engl J Med 1991;325:1738\u201340.","journal-title":"N Engl J Med"},{"key":"BF03044679_CR17","first-page":"777","volume":"33","author":"L Lichtenstein","year":"1942","unstructured":"Lichtenstein L, Jaffee HL. Fibrous dysplasia of bone. Arch Pathol 1942;33:777\u2013816.","journal-title":"Arch Pathol"},{"key":"BF03044679_CR18","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/S0140-6736(94)90069-8","volume":"343","author":"D Liens","year":"1994","unstructured":"Liens D, Delmas PD, Meunier PJ. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. Lancet 1994;343:953\u20134.","journal-title":"Lancet"},{"key":"BF03044679_CR19","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF02949307","volume":"157","author":"A Long","year":"1988","unstructured":"Long A, Longhlin T, Towers RP, et al. Polyostotic fibrous dysplasia with contrasting response to calcitonin and mithramycin: aetiological and therapeutical implications. Ir J Med Sci 1988;157:229\u201334.","journal-title":"Ir J Med Sci"},{"key":"BF03044679_CR20","first-page":"803","volume":"78","author":"CD Malchoff","year":"1994","unstructured":"Malchoff CD, Reardon G, MacGillivray DC, et al. An unusual presentation of McCune-Albright syndrom confirmed by an activating mutation of the Gs\u03b1-subunit from a bone lesion. J Clin Endocrinol Metab 1994;78:803\u20136.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03044679_CR21","first-page":"734","volume":"52","author":"D.J. McCune","year":"1936","unstructured":"McCune D.J.: Osteitis fibrosa cystica; the case of a nine year old girl who also exhibits precocious puberty, multiple pigmentation of the skin and hyperthyroidism. Am J Dis Child 1936;52:734\u20137.","journal-title":"Am J Dis Child"},{"key":"BF03044679_CR22","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1359\/jbmr.1997.12.10.1746","volume":"12","author":"RD Chapurlat","year":"1997","unstructured":"Chapurlat RD, Delmas PD, Liens D, et al. Long-term effects of intravenous pamidronate in fibrous dysplasia of bone. J Bone Miner Res 1997;12:1746\u201352.","journal-title":"J Bone Miner Res"},{"key":"BF03044679_CR23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1507\/endocrj1954.18.81","volume":"18","author":"H Morii","year":"1971","unstructured":"Morii H, Tanae A, Ibayashi H, et al. Effects of calcitonin in metastatic bone carcinoma, osteoporosis, polyostotic fibrous dysplasia and hypercalcemia. Endocrinol Jpn 1971;18:81\u201390.","journal-title":"Endocrinol Jpn"},{"key":"BF03044679_CR24","first-page":"43","volume":"6","author":"MD Poole","year":"1989","unstructured":"Poole MD. Surgical management of cranio-orbital bone dysplasias. Bone 1989;6:43\u20134.","journal-title":"Bone"},{"key":"BF03044679_CR25","first-page":"750","volume":"79","author":"A Shenker","year":"1994","unstructured":"Shenker A, Weinstein LS, Sweet DE, et al. An activating Gs\u03b1-mutation is present in fibrous dysplasia of bone in the McCune-Albright syndrome. J Clin Endocrinol Metab 1994;79:750\u20135.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03044679_CR26","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1093\/hmg\/4.9.1675","volume":"4","author":"A Shenker","year":"1995","unstructured":"Shenker A, Chanson P, Weinstein LS, et al. Osteoblastic cells derived from isolated lesions of fibrous dysplasia contain activating somatic mutations of the Gs<a> gene. Hum Molec Genet 1995;4:1675\u20136.","journal-title":"Hum Molec Genet"},{"key":"BF03044679_CR27","first-page":"2434","volume":"81","author":"AM Spiegel","year":"1996","unstructured":"Spiegel AM. Mutations in G proteins and G protein-coupled receptors in endocrine disease. J Clin Endocrinol Metab 1996;81:2434\u201342.","journal-title":"J Clin Endocrinol Metab"},{"key":"BF03044679_CR28","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0030-4220(61)80014-5","volume":"14","author":"HC Tanner","year":"1961","unstructured":"Tanner HC, Dahlin DC, Child DS. Sarcoma complicating fibrous dysplasia. Probable role of radiation therapy. Oral Surg 1961;14:837\u201346.","journal-title":"Oral Surg"},{"key":"BF03044679_CR29","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1148\/radiology.184.1.1609087","volume":"184","author":"EL Persijn van Meerten Van","year":"1992","unstructured":"Van Persijn van Meerten EL, Kroon HM, Papapoulos SE. Epi- and metaphyseal changes in children caused by administration of bisphosphonates. Radiology 1992;184:249\u201354.","journal-title":"Radiology"},{"key":"BF03044679_CR30","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1056\/NEJM199112123252403","volume":"325","author":"LS Weinstein","year":"1991","unstructured":"Weinstein LS, Shenker A, Gejman PV, et al. Activating mutations of the stimulatory G protein in the McCune-Albright syndrome. N Engl J Med 1991;325:1688\u201395.","journal-title":"N Engl J Med"},{"key":"BF03044679_CR31","first-page":"344","volume-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","author":"MP Whyte","year":"1993","unstructured":"Whyte MP. Fibrous dysplasia. In: Favus MJ, eds. Primer on the metabolic bone diseases and disorders of mineral metabolism, New York: Raven Press, 1993:344\u20136."},{"key":"BF03044679_CR32","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1507\/endocrj1954.30.651","volume":"30","author":"K Yamamoto","year":"1983","unstructured":"Yamamoto K, Maeyaa I, Kishimoto M, et al. Suppressive effect of elcatonin, an eel calcitonin analogue, on excessive hydroxyproline excretion in polyostotic fibrous dysplasia (McCune-Albright\u2019s syndrome). Endocrinol Jpn 1983;30:651\u20136.","journal-title":"Endocrinol Jpn"},{"key":"BF03044679_CR33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1172\/JCI118773","volume":"98","author":"T Yamamoto","year":"1996","unstructured":"Yamamoto T, Ozono K, Kasayama S, et al. Increased IL-6 production by cells isolated from the fibrous bone dysplasia tissues in patients with McCune-Albright syndrome. J Clin Invest 1996;98:30\u20135.","journal-title":"J Clin Invest"}],"container-title":["Medizinische Klinik"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03044679.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/BF03044679\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/BF03044679","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,21]],"date-time":"2019-05-21T19:49:28Z","timestamp":1558468168000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/BF03044679"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[1998,6]]}},"alternative-id":["BF03044679"],"URL":"https:\/\/doi.org\/10.1007\/bf03044679","relation":{},"ISSN":["0723-5003","1615-6722"],"issn-type":[{"value":"0723-5003","type":"print"},{"value":"1615-6722","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,6]]}}}